Neurite degeneration in human neuronal SH-SY5Y cells as an indicator of axonopathy

Neuromethods

Volumn 56, Issue , 2011, Pages 255-268

  Forsby, Anna ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Axonopathy; General cytotoxicity; Neurite degeneration; Neuroblastoma cell line; SH SY5Y

Indexed keywords

ACRYLAMIDE; MUSCARINIC RECEPTOR;

ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL ELONGATION; CELL STRAIN; CELL STRAIN SH SY5Y; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIABETIC NEUROPATHY; HUMAN; HUMAN CELL; MORPHOLOGY; NERVE CELL CULTURE; NERVE CELL DEGENERATION; NERVE FIBER GROWTH; NEURITE; NEUROBLASTOMA; NEUROPATHY; NEUROTOXICITY; OSMOLARITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 79952615145     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-61779-077-5_12     Document Type: Article

References (26)

1. Biedler JL, Helson L, Spengler BA (1973) Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652
2. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38:3751-3757 (Pubitemid 9045201)
3. Perez-Polo JR, Tiffany-Castiglioni E, Ziegler MG, Werrbach-Perez K (1982) Effect of nerve growth factor on catecholamine metabolism in a human neuroblastoma clone (SY5Y). Dev Neurosci 5:418-423 (Pubitemid 13220970)
4. Fang J, Zuo D, Yu PH (1995) Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N-methyl-4- phenylpyridinium (MPP+) towards cultured dopaminergic neuroblastoma cells. Psychopharmacology (Berl) 121:373-378
5. Oyagi A, Oida Y, Hara H et al (2008) Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease. Brain Res 1214:169-176
6. Holback S, Adlerz L, Iverfeldt K (2005) Increased processing of APLP2 and APP with concomitant formation of APP intracellular domains in BDNF and retinoic aciddifferentiated human neuroblastoma cells. J Neurochem 95:1059-1068 (Pubitemid 41713490)
7. Uhrig M, Brechlin P, Jahn O et al (2008) Upregulation of CRABP1 in human neuroblastoma cells overproducing the Alzheimertypical Abeta42 reduces their differentiation potential. BMC Med 6:38
8. Wang H, Xu Y, Yan J et al (2009) Acteoside protects human neuroblastoma SH-SY5Y cells against beta-amyloid-induced cell injury. Brain Res 1283:139-147
9. Gustafsson H, Runesson J, Lundqvist J, Lindegren H, Axelsson V, Forsby A (2010) Neurofunctional endpoints assessed in human neuroblastoma SH-SY5Y cells for estimation of acute systemic toxicity. Toxicol Appl Pharmacol 245(2):191-202
10. Bottenstein JE, Sato GH (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 76:514-517 (Pubitemid 9106659)
11. Pahlman S, Ruusala AI, Abrahamsson L, Mattsson ME, Esscher T (1984) Retinoic acid-induced differentiation of cultured human neuroblastoma cells: A comparison with phorbolester-induced differentiation. Cell Differ 14:135-144 (Pubitemid 14089031)
12. El Andaloussi-Lilja J, Lundqvist J, Forsby A (2009) TRPV1 expression and activity during retinoic acid-induced neuronal differentiation. Neurochem Int 55:768-774
13. Spencer PS, Schaumburg HH (1974) A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms. Can J Neurol Sci 1:152-169
14. Lotti M (1991) The pathogenesis of organophosphate polyneuropathy. Crit Rev Toxicol 21:465-487
15. Ehrich M, Correll L, Veronesi B (1994) Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells. Neurotoxicology 15: 309-313
16. Hong MS, Hong SJ, Barhoumi R et al (2003) Neurotoxicity induced in differentiated SK-NSH- SY5Y human neuroblastoma cells by organophosphorus compounds. Toxicol Appl Pharmacol 186:110-118 (Pubitemid 36298620)
17. Cho T, Tiffany-Castiglioni E (2004) Neurofilament 200 as an indicator of differences between mipafox and paraoxon sensitivity in Sy5Y neuroblastoma cells. J Toxicol Environ Health A 67:987-1000 (Pubitemid 38822690)
18. Forsby A, Pilli F, Bianchi V, Walum E (1995) Determination of critical neurotoxic concentrations in human neuroblastoma (SH-SY5Y) cells. Altern Lab Anim 23: 800-811 (Pubitemid 3012931)
19. Nordin-Andersson M, Walum E, Kjellstrand P, Forsby A (2003) Acrylamide-induced effects on general and neurospecific cellular functions during exposure and recovery. Cell Biol Toxicol 19:43-51 (Pubitemid 36286345)
20. Saxena S, Caroni P (2007) Mechanisms of axon degeneration: From development to disease. Prog Neurobiol 83:174-191 (Pubitemid 47484043)
21. Axelsson V, Holback S, Sjogren M, Gustafsson H, Forsby A (2006) Gliotoxin induces caspase- dependent neurite degeneration and calpain-mediated general cytotoxicity in differentiated human neuroblastoma SH-SY5Y cells. Biochem Biophys Res Commun 345:1068-1074 (Pubitemid 43776524)
22. DeJongh J, Nordin-Andersson M, Ploeger BA, Forsby A (1999) Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulations. Toxicol Appl Pharmacol 158:261-268 (Pubitemid 29382944)
23. Wenehed V, Solyakov A, Thylin I, Haggblom P, Forsby A (2003) Cytotoxic response of Aspergillus fumigatus-produced mycotoxins on growth medium, maize and commercial animal feed substrates. Food Chem Toxicol 41:395-403 (Pubitemid 36015777)
24. Gustafsson H, Soderdahl T, Jonsson G, Bratteng JO, Forsby A (2004) Insulin-like growth factor type 1 prevents hyperglycemiainduced uncoupling protein 3 down-regulation and oxidative stress. J Neurosci Res 77:285-291 (Pubitemid 38859413)
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
26. Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA (1989) Phenotypic diversification in human neuroblastoma cells: Expression of distinct neural crest lineages. Cancer Res 49:219-225 (Pubitemid 19024435)